Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series.
Nayoung RyooHyoshin SonJean Hee KimDae Woong BaeJae Young AnPublished in: Journal of Korean medical science (2024)
Guillain-Barré syndrome (GBS) is an autoimmune-driven condition characterized by acute polyneuropathy, often emerging as a sequel to prior infections or vaccinations. This study presents the first reported cases of GBS emerging after the full recovery from coronavirus disease 2019 (COVID-19) infection in Korea. Despite experiencing mild acute COVID-19 symptoms, these patients faced substantial weakness attributed to GBS, significantly affecting their daily lives. The timely administration of intravenous immunoglobulin treatment halted the progression of symptoms, underscoring the critical importance of early intervention. These cases highlight the potential for neurological complications associated with COVID-19 and underscore the necessity for continuous monitoring and timely medical care.
Keyphrases
- coronavirus disease
- liver failure
- sars cov
- end stage renal disease
- drug induced
- respiratory failure
- newly diagnosed
- respiratory syndrome coronavirus
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- aortic dissection
- case report
- multiple sclerosis
- physical activity
- prognostic factors
- high dose
- peritoneal dialysis
- sleep quality
- hepatitis b virus
- risk assessment
- low dose
- intensive care unit
- blood brain barrier
- acute respiratory distress syndrome
- mechanical ventilation
- patient reported